Daniel W Carney

Daniel W Carney

Takeda Pharmaceutical Company Limited - Osaka / Japan
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4404370
武田薬品工業株式会社
person_outline Daniel W Carney's MOST POPULAR ARTICLES
1-) Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activityDW Carney, KR Schmitz, JV Truong, RT Sauer, JK SelloJournal of the American Chemical Society 136 (5), 1922-1929, 2014982014
2-) Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate deliveryKR Schmitz, DW Carney, JK Sello, RT SauerProceedings of the National Academy of Sciences 111 (43), E4587-E4595, 2014892014
3-) A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomavirusesCDS Nelson, DW Carney, A Derdowski, A Lipovsky, GV Gee, B O’Hara, ...MBio 4 (6), e00729-13, 2013692013
4-) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsML Boby, D Fearon, M Ferla, M Filep, L Koekemoer, MC Robinson, ...Science 382 (6671), eabo7201, 2023642023
5-) A simple fragment of cyclic acyldepsipeptides is necessary and sufficient for ClpP activation and antibacterial activityDW Carney, CL Compton, KR Schmitz, JP Stevens, RT Sauer, JK SelloChemBioChem 15 (15), 2216-2220, 2014452014